首页> 美国卫生研究院文献>Gynecologic Oncology Reports >Less radical surgery for women with early stage cervical cancer: Our experience on radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy
【2h】

Less radical surgery for women with early stage cervical cancer: Our experience on radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy

机译:早期宫颈癌女性的较少根治性手术:我们在根治性阴道气管切除术和腹腔镜盆腔淋巴结清扫术方面的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the use of radical vaginal trachelectomy (RVT) with pelvic laparoscopic lymphadenectomy (LPL) in patients with early stages cervical cancer (FIGO stage IA2-IB1). This is a case series prospectively collected over a 6-year period (2011–2017) at the Ipswich hospital, UK. Cases were compared to a group of women with a similar stage of cervical cancer, but treated with radical hysterectomy (RH) and pelvic lymphadenectomy (PL). A total of 19 patients (group 1) underwent RVT and LPL, and 51 (group 2) had RH and PL. We included: 5/19 (26%) stage IA2 and 14/19 (74%) stage IB1. Among those, we had: 12/19 (63%) cases of squamous cell carcinoma (SCC), 7/19(37%) of adenocarcinoma. Mean hospital stay was 2.7 days (range 2–4) in group 1 versus 4.8 days (range 3–8) group 2 (p-value = 0.173). The complication rate was not statistically different between the two groups 4/19(21%) and 7/51(14%) (p-value 0.169). The mean follow-up period was 47.3 months (range 7–78) in both groups. There were no cases of recurrence in group 1 and 2/51(4%) cases in group 2, but the difference was not significant (p-value = 0.497). In our experience RVT in well-selected patients is a safe treatment option with similar oncological outcomes when compared to patients undergoing more extensive surgery for the same early stage cervical cancer.
机译:我们报告在患有早期子宫颈癌(FIGO IA2-IB1期)的患者中使用根治性阴道气管切开术(RVT)和盆腔腹腔镜淋巴结清扫术(LPL)。该病例系列是在英国伊普斯威奇医院过去6年(2011-2017年)中进行前瞻性收集的。将病例与一组患有相似宫颈癌但接受了根治性子宫切除术(RH)和盆腔淋巴结切除术(PL)的妇女进行比较。共有19例患者(第1组)接受了RVT和LPL,其中51例(第2组)患有RH和PL。我们包括:5/19(26%)阶段IA2和14/19(74%)阶段IB1。其中,我们患有:12/19(63%)鳞状细胞癌(SCC),7/19(37%)腺癌。第一组的平均住院天数为2.7天(2-4天),而第二组的平均住院天数为4.8天(3-8天)(p值== 0.173)。两组的并发症发生率在4/19(21%)和7/51(14%)之间无统计学差异(p值0.169)。两组的平均随访时间为47.3个月(范围7–78)。第1组无复发病例,第2组无2/51(4%)病例复发,但差异无统计学意义(p值= 0.497)。根据我们的经验,与接受相同早期子宫颈癌的更广泛手术的患者相比,对于选择良好的患者,RVT是一种安全的治疗选择,其肿瘤学结果相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号